Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denise Bijlenga

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Experimental Eye Research|July 26, 2015
Post-illumination pupil response after blue light: Reliability of optimized melanopsin-based phototransduction assessmentWisse P van der Meijden, Bart H W te Lindert, Denise Bijlenga, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 27, 2014
Determinants of health-related quality of life in the postpartum period after obstetric complicationsBabette W Prick, Denise Bijlenga, A J Gerard Jansen, et al.
Clinical Obstetrics and Gynecology|April 10, 2024
"Hypertension in Pregnancy Intervention Trial At Term" and "Disproportionate Intrauterine Growth Intervention Trial At Term" StudiesMarielle G van Pampus, Joris A M van der Post, Corine J Verhoeven, et al.
Hypertension in Pregnancy|July 12, 2011
Health-related quality of life after induction of labor versus expectant monitoring in gestational hypertension or preeclampsia at termDenise Bijlenga, Corine M Koopmans, Erwin Birnie, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 7, 2011
Maternal health-related quality of life after induction of labor or expectant monitoring in pregnancy complicated by intrauterine growth retardation beyond 36 weeksDenise Bijlenga, Kim E Boers, Erwin Birnie, et al.
BMC Pregnancy and Childbirth|July 10, 2007
Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL-trial)David P van der Ham, Jan G Nijhuis, Ben Willem J Mol, et al.
Lancet (London, England)|August 7, 2009
Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trialCorine M Koopmans, Denise Bijlenga, Henk Groen, et al.
BMC Pregnancy and Childbirth|July 12, 2007
Disproportionate Intrauterine Growth Intervention Trial At Term: DIGITATKim E Boers, Denise Bijlenga, Ben W J Mol, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 8, 2014
Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial)Sylvia M C Vijgen, David P van der Ham, Denise Bijlenga, et al.
BMC Pregnancy and Childbirth|July 31, 2007
Induction of labour versus expectant monitoring in women with pregnancy induced hypertension or mild preeclampsia at term: the HYPITAT trialCorine M Koopmans, Denise Bijlenga, Jan G Aarnoudse, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Experimental Eye Research|July 26, 2015
Post-illumination pupil response after blue light: Reliability of optimized melanopsin-based phototransduction assessmentWisse P van der Meijden, Bart H W te Lindert, Denise Bijlenga, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 27, 2014
Determinants of health-related quality of life in the postpartum period after obstetric complicationsBabette W Prick, Denise Bijlenga, A J Gerard Jansen, et al.
Clinical Obstetrics and Gynecology|April 10, 2024
"Hypertension in Pregnancy Intervention Trial At Term" and "Disproportionate Intrauterine Growth Intervention Trial At Term" StudiesMarielle G van Pampus, Joris A M van der Post, Corine J Verhoeven, et al.
Hypertension in Pregnancy|July 12, 2011
Health-related quality of life after induction of labor versus expectant monitoring in gestational hypertension or preeclampsia at termDenise Bijlenga, Corine M Koopmans, Erwin Birnie, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 7, 2011
Maternal health-related quality of life after induction of labor or expectant monitoring in pregnancy complicated by intrauterine growth retardation beyond 36 weeksDenise Bijlenga, Kim E Boers, Erwin Birnie, et al.
BMC Pregnancy and Childbirth|July 10, 2007
Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL-trial)David P van der Ham, Jan G Nijhuis, Ben Willem J Mol, et al.
Lancet (London, England)|August 7, 2009
Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trialCorine M Koopmans, Denise Bijlenga, Henk Groen, et al.
BMC Pregnancy and Childbirth|July 12, 2007
Disproportionate Intrauterine Growth Intervention Trial At Term: DIGITATKim E Boers, Denise Bijlenga, Ben W J Mol, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 8, 2014
Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial)Sylvia M C Vijgen, David P van der Ham, Denise Bijlenga, et al.
BMC Pregnancy and Childbirth|July 31, 2007
Induction of labour versus expectant monitoring in women with pregnancy induced hypertension or mild preeclampsia at term: the HYPITAT trialCorine M Koopmans, Denise Bijlenga, Jan G Aarnoudse, et al.
Pageof 7